Skip to Content

Bacitracin / polymyxin b ophthalmic Pregnancy and Breastfeeding Warnings

Bacitracin / polymyxin b ophthalmic is also known as: AK-Poly-Bac, Polycin, Polycin-B, Polysporin Ophthalmic, Polytracin Ophthalmic

Medically reviewed by Drugs.com. Last updated on Feb 3, 2018.

Bacitracin / polymyxin b ophthalmic Pregnancy Warnings

Animal studies have not been reported. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if clearly needed.

US FDA pregnancy category: C

See references

Bacitracin / polymyxin b ophthalmic Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments:
-Both components are poorly absorbed after topical application; both are considered low risk to nursing infants.

See references

References for pregnancy information

  1. "Product Information. Polysporin (bacitracin-polymyxin B ophthalmic)." Monarch Pharmaceuticals Inc, Bristol, TN.

References for breastfeeding information

  1. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):
  2. "Product Information. Polysporin (bacitracin-polymyxin B ophthalmic)." Monarch Pharmaceuticals Inc, Bristol, TN.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide